Sunshine Biopharma Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2018 | -10.6% | -182.8% | -291.4% |
| Dec 2018 | -10.6% | 140.7% | 371.5% |
| Mar 2019 | 45.6% | -59,324.8% | -98,321.4% |
| Jun 2019 | 51.9% | -2,182.6% | -23,438.5% |
| Sep 2019 | 27.8% | -2,766.0% | -4,780.8% |
| Dec 2019 | 60.4% | -2,373.9% | -3,757.3% |
| Mar 2020 | 65.0% | -339.6% | -849.0% |
| Jun 2020 | 65.9% | -848.9% | -5,991.7% |
| Sep 2020 | 63.0% | -392.3% | -4,073.4% |
| Dec 2020 | 62.6% | -1,225.6% | -3,868.9% |
| Mar 2021 | 53.8% | -3,184.5% | -15,440.4% |
| Jun 2021 | 65.0% | -735.0% | -5,445.1% |
| Sep 2021 | 61.3% | -985.1% | -8,018.5% |
| Dec 2021 | 28.0% | -328.5% | 783.8% |
| Mar 2022 | 51.2% | -997.5% | -1,008.0% |
| Jun 2022 | 50.3% | -462.9% | -358.5% |
| Sep 2022 | 50.5% | -1,293.6% | -1,097.1% |
| Dec 2022 | 37.8% | -593.0% | -596.8% |
| Mar 2023 | 37.4% | -37.4% | -34.8% |
| Jun 2023 | 35.1% | -18.2% | -16.2% |
| Sep 2023 | 33.4% | -13.1% | -10.9% |
| Dec 2023 | 33.4% | -15.1% | -16.3% |
| Mar 2024 | 31.2% | -17.9% | -17.0% |
| Jun 2024 | 25.3% | -13.6% | -5.3% |
| Sep 2024 | 34.0% | -13.1% | -14.2% |
| Dec 2024 | 32.2% | -21.7% | -22.5% |
| Mar 2025 | 30.7% | -14.6% | -13.3% |
| Jun 2025 | 36.4% | -21.8% | -18.8% |
| Sep 2025 | 32.6% | -11.5% | -9.4% |
| Dec 2025 | 35.3% | -20.9% | -25.0% |
| Mar 2026 | 27.0% | -17.3% | -15.4% |
| Jun 2026 | 26.2% | -17.4% | -16.9% |